Journal
CANCER RESEARCH
Volume 82, Issue 10, Pages 1937-1952Publisher
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-21-3038
Keywords
-
Categories
Funding
- National Natural Science Foundation of China [82172937, 81972247, 81930123, 81790252]
- Natural Science Foundation of Shanghai [18ZR1407900]
Ask authors/readers for more resources
DHX37, a dysregulated RNA helicase in hepatocellular carcinoma (HCC), interacts with PLRG1 to promote cell proliferation and cyclin D1 expression. This cooperative mechanistic interaction contributes to liver cancer progression and improves our understanding of epigenetic and transcriptional dysregulations in HCC mediated by RNA helicases and superenhancers.
RNA helicases are dysregulated in tumors. Here, we identified DHX37 as one of the top RNA helicase genes with upregulated expression in hepatocellular carcinoma (HCC). DHX37 promoted proliferation of liver cancer cells in vitro and in vivo. Epigenomic profiling of DHX37-knockdown and control HCC cells revealed that DHX37 is associated with superenhancer activity. Mechanis-tically, DHX37 interacted with pleiotropic regulator 1 (PLRG1) to transcriptionally activate cyclin D1 (CCND1) expression via co -occupation of its promoter and superenhancer elements. DHX37 and PLRG1 promoted liver cancer cell proliferation and contributed to the poor prognosis of patients with HCC. Importantly, CCND1 inhibitors were effective as antiproliferative agents for liver cancer. These results together demonstrate a cooperative mechanistic interaction between DHX37 and PLRG1 that regulates CCND1 expression and promotes liver cancer progression, advancing our understanding of the epigenetic and transcriptional dysregulations mediated by RNA helicases and superenhancers in HCC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available